Sharma Sameer, Chen Zhibin, Rychkova Maria, Dunne John, Lee Judy, Lawn Nicholas, Kwan Patrick
Department of Neurosciences, Central Clinical School, Monash University, Alfred Hospital, The Alfred Centre, 99 Commercial Road, Melbourne, VIC 3004, Australia.
Department of Neurosciences, Central Clinical School, Monash University, Alfred Hospital, The Alfred Centre, 99 Commercial Road, Melbourne, VIC 3004, Australia; Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia; School of Public Health and Preventive Medicine, Monash University, 533 St Kilda Road, Melbourne, VIC 3004, Australia.
Epilepsy Behav. 2021 Apr;117:107880. doi: 10.1016/j.yebeh.2021.107880. Epub 2021 Mar 9.
To compare the outcomes between immediate and deferred treatments in patients diagnosed after one or multiple (two or more) seizures.
Our observational study investigated seizure recurrence and 12-month seizure remission in patients with newly diagnosed epilepsy, comparing immediate to deferred treatment in patients diagnosed after one seizure or after two or more seizures.
Of 598 patients (62% male, median age 39 years), 347 (58%) were treated at diagnosis and 251 (42%) received deferred or no treatment. Seizure recurrence was higher with deferred treatment both in patients diagnosed after two or more seizures (n = 363; adjusted hazard ratio [aHR] = 2.38, 95% confidence interval [CI]: 1.79-3.14, p < 0.001) and after one seizure (n = 235; aHR = 1.41, 95% CI: 0.995-1.99, p = 0.05). Cumulative seizure recurrence rates at two years in patients diagnosed after two or more seizures were 73% with deferred treatment and 49% with immediate treatment (risk-factor-corrected number-needed-to-treat [NNT] = 4), and in those diagnosed after one seizure the rates were 60% and 51% (NNT = 8). Of 380 patients with eligible follow-up (median 4.3 years), 287 (76%) had been in seizure remission for at least one year and 211 (56%) remained in remission at last follow-up. Long-term remission rates were similar between immediate and deferred treatments, and between patients diagnosed after one seizure and those with two or more seizures.
Immediate rather than deferred treatment was less likely to influence seizure recurrence in patients diagnosed with epilepsy after a single seizure than in those diagnosed after two or more seizures, and showed no differences in long-term seizure freedom.
比较单次发作或多次(两次或更多次)发作后确诊的患者立即治疗与延迟治疗的效果。
我们的观察性研究调查了新诊断癫痫患者的癫痫复发情况和12个月癫痫缓解情况,比较单次发作后或两次或更多次发作后确诊的患者立即治疗与延迟治疗的效果。
在598例患者中(男性占62%,中位年龄39岁),347例(58%)在诊断时接受了治疗,251例(42%)接受了延迟治疗或未接受治疗。在两次或更多次发作后确诊的患者(n = 363;调整后风险比[aHR] = 2.38,95%置信区间[CI]:1.79 - 3.14,p < 0.001)和单次发作后确诊的患者(n = 235;aHR = 1.41,95% CI:0.995 - 1.99,p = 0.05)中,延迟治疗的癫痫复发率均较高。两次或更多次发作后确诊的患者中,延迟治疗组两年累计癫痫复发率为73%,立即治疗组为49%(风险因素校正需治疗人数[NNT] = 4);单次发作后确诊的患者中,复发率分别为60%和51%(NNT = 8)。在380例符合随访条件的患者中(中位随访4.3年),287例(76%)至少有一年癫痫缓解,211例(56%)在最后一次随访时仍处于缓解状态。立即治疗和延迟治疗之间以及单次发作后确诊的患者与两次或更多次发作后确诊的患者之间的长期缓解率相似。
与两次或更多次发作后确诊的癫痫患者相比,单次发作后确诊的癫痫患者立即治疗而非延迟治疗更不可能影响癫痫复发,且在长期无癫痫发作方面无差异。